If you have an IRB-related question, others probably do too! This column is an opportunity to answer your questions. Check in each month to see the answers to some of the most common questions asked by the research community. To find more questions from previous months, click here to search the archive.
Please send your questions to email@example.com.
A: Collecting information from individuals in order to screen them for entry into the main component of a study is still a research procedure that requires either full consent or a brief screening consent that does not include all elements of consent. If you are not associating identifiers with health information on the prescreening questionnaire, then it is acceptable to use a brief screening consent.
This screening consent language can be included as a paragraph that is read verbally to potential participants, and you can either include it at the beginning of the Screening Questionnaire or attach it as a separate document.
You can create a Brief Screening Agreement consent paragraph using the following template: http://www.bumc.bu.edu/irb/files/2016/12/Brief-Screening-Agreement.docx, and attach this as a separate document, or include the language at the top of the Screening questionnaire.If you will be collecting identifiers and health information from the people being screened, then you will need to use the full consent template, and they will need to sign the HIPAA Authorization language contained therein (the Use and Disclosure of Your Health Information section).